@article{3181216,
    title = "Ibrutinib/Rituximab versus Placebo/Rituximab: A Randomized, Phase 3
Trial in Waldenstrom's Macroglobulinemia (iNNOVATE)",
    author = "Palomba, M. Lia and Dimopoulos, Meletios A. and Tedeschi, Alessandra and and Trotman, Judith and Garcia-Sanz, Ramon and MacDonald, David and Leblond, and Veronique and Mahe, Beatrice and Herbaux, Charles and Tam, Constantine and and Matous, Jeffrey V. and Shustik, Chaim and Kastritis, Efstathios and and Treon, Steven P. and Li, Jianling and Salman, Zeena and Graef, Thorsten and and Buske, Christian",
    journal = "Clinical Lymphoma Myeloma & Leukemia",
    year = "2018",
    volume = "18",
    number = "1",
    pages = "S283",
    publisher = "CIG MEDIA GROUP, LP",
    issn = "2152-2650, 2152-2669",
    doi = "10.1016/j.clml.2018.07.217",
    keywords = "Waldenstrom's macroglobulinemia; ibrutinib; combination therapy;
rituximab"
}